Abstract
In order to adapt African programs for antiretroviral treatment (ART) to childrens needs, a good understanding of the unique features of pediatric HIV in Africa and realistic expectations of the results of such programs are crucial. We compared pediatric HIV in African settings to pediatric HIV in Western settings and to adult HIV in African settings. As an illustration, we also compared baseline characteristics and ART-outcomes from 15 African pediatric studies, 11 Western pediatric studies and 15 studies of African adults. Several differences in diagnostic, clinical, immunological and virological characteristics were identified, as well as variations in the most influential factors for disease progression and response to ART. Environmental factors may influence disease progression, mortality, loss to follow-up, adherence and the need to adapt the regimen. Many of the responses to ART are two-phased, the first phase taking longer in children than in adults. The selected African pediatric programs recorded a higher increase in median CD4-percent than the selected Western pediatric programs and a higher increase in CD4-count than the selected African adult programs. Compared to the adult programs, the African pediatric programs had lower drop-out rates, higher reported adherence levels and comparable mortality rates. The Western pediatric programs, however, had the lowest mortality rates. While several challenges complicate comparisons between ART-programs, increased knowledge of the unique features of pediatric HIV in Africa may greatly assist in improving pediatric HIV care on a global level.
Keywords: Pediatric HIV, antiretroviral therapy, Africa, ART-outcome, features, comparison
Current HIV Research
Title: The Unique Features of Pediatric HIV-1 in Sub-Saharan Africa
Volume: 6 Issue: 4
Author(s): Anniek J. De Baets, Jose Ramet, Philippe Msellati and Philippe Lepage
Affiliation:
Keywords: Pediatric HIV, antiretroviral therapy, Africa, ART-outcome, features, comparison
Abstract: In order to adapt African programs for antiretroviral treatment (ART) to childrens needs, a good understanding of the unique features of pediatric HIV in Africa and realistic expectations of the results of such programs are crucial. We compared pediatric HIV in African settings to pediatric HIV in Western settings and to adult HIV in African settings. As an illustration, we also compared baseline characteristics and ART-outcomes from 15 African pediatric studies, 11 Western pediatric studies and 15 studies of African adults. Several differences in diagnostic, clinical, immunological and virological characteristics were identified, as well as variations in the most influential factors for disease progression and response to ART. Environmental factors may influence disease progression, mortality, loss to follow-up, adherence and the need to adapt the regimen. Many of the responses to ART are two-phased, the first phase taking longer in children than in adults. The selected African pediatric programs recorded a higher increase in median CD4-percent than the selected Western pediatric programs and a higher increase in CD4-count than the selected African adult programs. Compared to the adult programs, the African pediatric programs had lower drop-out rates, higher reported adherence levels and comparable mortality rates. The Western pediatric programs, however, had the lowest mortality rates. While several challenges complicate comparisons between ART-programs, increased knowledge of the unique features of pediatric HIV in Africa may greatly assist in improving pediatric HIV care on a global level.
Export Options
About this article
Cite this article as:
De Baets J. Anniek, Ramet Jose, Msellati Philippe and Lepage Philippe, The Unique Features of Pediatric HIV-1 in Sub-Saharan Africa, Current HIV Research 2008; 6 (4) . https://dx.doi.org/10.2174/157016208785132491
DOI https://dx.doi.org/10.2174/157016208785132491 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
A Review of Patents on Therapeutic Potential and Delivery of Hydroge n Sulfide
Recent Patents on Drug Delivery & Formulation Classical Inhibitors of NOX NAD(P)H Oxidases Are Not Specific
Current Drug Metabolism Advances in Treating the Ischaemic Diabetic Foot
Current Vascular Pharmacology Editorial: Statin Potency, LDL Receptors and New Onset Diabetes
Current Vascular Pharmacology α-Lipoic Acid Supplementation: A Tool for Obesity Therapy?
Current Pharmaceutical Design Use of N-acetyl-cysteine to Prevent Nephrotoxicity Associated with Iodinated Contrast Agents
Current Drug Therapy Meet Our Editorial Board Member
Current Cardiology Reviews Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Neuropeptide Y Induces Cardiomyocyte Hypertrophy <i>via</i> Attenuating miR-29a-3p in Neonatal Rat Cardiomyocytes
Protein & Peptide Letters Chemical and Pharmacological Aspects of Heteroaryl-Nitrones
Current Medicinal Chemistry Phytol a Natural Diterpenoid with Pharmacological Applications on Central Nervous System: A Review
Recent Patents on Biotechnology Psoriasis vulgaris and Psoriasis pustulosa – Epidemiology, Quality of Life, Comorbidities and Treatment
Current Rheumatology Reviews Apo-E4 Allele in Conjunction with Aβ42 and Tau in CSF: Biomarker for Alzheimers Disease
Current Alzheimer Research Pulmonary Arterial Hypertension
Current Vascular Pharmacology Antioxidants in Wild Mushrooms
Current Medicinal Chemistry Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?
Current Pharmaceutical Design Advances in Biologic Agents for the Treatment of Rheumatoid Arthritis
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Novel Drugs and the Response to Hypoxia: HIF Stabilizers and Prolyl Hydroxylase
Recent Patents on Cardiovascular Drug Discovery Not So Simple: Situating Postgenomics Personalized Medicine in the Regional Context in Africa for Global and Womens Health
Current Pharmacogenomics and Personalized Medicine Progress and Survey of Mobile Image Feature Recognition
Recent Patents on Computer Science